252 related articles for article (PubMed ID: 26100990)
1. Clinical Indications and Adverse Reactions of Platelet Apheresis.
Amanat ST; Shakoor HA; Raza M; Khan N; Rauf A
J Coll Physicians Surg Pak; 2015 Jun; 25(6):403-6. PubMed ID: 26100990
[TBL] [Abstract][Full Text] [Related]
2. Frequency of adverse events in plateletpheresis donors in regional transfusion centre in North India.
Patidar GK; Sharma RR; Marwaha N
Transfus Apher Sci; 2013 Oct; 49(2):244-8. PubMed ID: 23830186
[TBL] [Abstract][Full Text] [Related]
3. Rates of vaso-vagal reactions among first time teenaged whole blood, double red cell, and plateletpheresis donors.
Reiss RF; Harkin R; Lessig M; Mascari J
Ann Clin Lab Sci; 2009; 39(2):138-43. PubMed ID: 19429799
[TBL] [Abstract][Full Text] [Related]
4. Incidence and severity of adverse events among platelet donors: A three-year retrospective study.
Almutairi H; Salam M; Batarfi K; Alharbi D; Wani F; Almutairi A; Al-Shammari B; Al-Surimi K
Medicine (Baltimore); 2020 Dec; 99(52):e23648. PubMed ID: 33350744
[TBL] [Abstract][Full Text] [Related]
5. Donor complication rates in whole blood, plasma and platelet donors: Age versus experience.
Paalvast Y; Díaz Padilla N; Bruijns S; Wiersum-Osselton J; Molenaar T
Transfusion; 2024 May; 64(5):854-865. PubMed ID: 38385649
[TBL] [Abstract][Full Text] [Related]
6. Adverse reactions in blood and apheresis donors: experience from two Italian transfusion centres.
Crocco I; Franchini M; Garozzo G; Gandini AR; Gandini G; Bonomo P; Aprili G
Blood Transfus; 2009 Jan; 7(1):35-8. PubMed ID: 19290078
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of donor factors contributing to plateletpheresis yields among apheresis platelet donors.
Woodall WJ; Nguyen VQ; Tran MH
J Clin Apher; 2014 Jun; 29(3):139-47. PubMed ID: 24222645
[TBL] [Abstract][Full Text] [Related]
8. A 3-year analysis of plateletpheresis donor deferral pattern in a tertiary health care institute: assessing the current donor selection criteria in Indian scenario.
Tondon R; Pandey P; Chaudhry R
J Clin Apher; 2008; 23(4):123-8. PubMed ID: 18615635
[TBL] [Abstract][Full Text] [Related]
9. Adverse events in platelet apheresis donors: A multivariate analysis in a hospital-based program.
Despotis GJ; Goodnough LT; Dynis M; Baorto D; Spitznagel E
Vox Sang; 1999; 77(1):24-32. PubMed ID: 10474087
[TBL] [Abstract][Full Text] [Related]
10. Plateletpheresis in 90- to 110-pound donors using the CS-3000 blood cell separator.
Buchholz DH; Squires JE; Herman JH; Ng AT; Anderson JK; Hedberg SL
Transfusion; 1997 Jul; 37(7):715-8. PubMed ID: 9225935
[TBL] [Abstract][Full Text] [Related]
11. Blood donors--Serious adverse reactions (SAR) 2010-2014 EFS Châteauroux, France.
Riga A; Sapey T; Bacanu M; Py JY; Dehaut F
Transfus Clin Biol; 2015 Jun; 22(2):62-5. PubMed ID: 25997383
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of automated plateletpheresis using five different apheresis systems in a tertiary care hospital.
Chaudhary R; Das SS; Khetan D; Ojha S; Verma S
Transfus Apher Sci; 2009 Apr; 40(2):99-103. PubMed ID: 19237317
[TBL] [Abstract][Full Text] [Related]
13. Frequency of immediate adverse effects associated with apheresis donation.
McLeod BC; Price TH; Owen H; Ciavarella D; Sniecinski I; Randels MJ; Smith JW
Transfusion; 1998 Oct; 38(10):938-43. PubMed ID: 9767744
[TBL] [Abstract][Full Text] [Related]
14. The relationship of platelet yield, donor's characteristic and apheresis instruments in China.
Yin G; Xu J; Shen Z; Wang Y; Zhu F; Lv H
Transfus Apher Sci; 2013 Dec; 49(3):608-12. PubMed ID: 23978555
[TBL] [Abstract][Full Text] [Related]
15. A Retrospective Analysis of Apheresis Donor Deferral and Adverse Reactions at a Tertiary Care Centre in India.
Arora D; Garg K; Kaushik A; Sharma R; Rawat DS; Mandal AK
J Clin Diagn Res; 2016 Nov; 10(11):EC22-EC24. PubMed ID: 28050376
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for complications in donors at first and repeat whole blood donation: a cohort study with assessment of the impact on donor return.
Wiersum-Osselton JC; Marijt-van der Kreek T; Brand A; Veldhuizen I; van der Bom JG; de Kort W
Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s28-36. PubMed ID: 23867173
[TBL] [Abstract][Full Text] [Related]
17. Blood donor haemovigilance in Yaoundé, Cameroon.
Nchinda EC; Tagny CT; Mbanya D
Transfus Med; 2012 Aug; 22(4):257-61. PubMed ID: 22630141
[TBL] [Abstract][Full Text] [Related]
18. Moderate and severe adverse events associated with apheresis donations: incidences and risk factors.
Yuan S; Ziman A; Smeltzer B; Lu Q; Goldfinger D
Transfusion; 2010 Feb; 50(2):478-86. PubMed ID: 19843285
[TBL] [Abstract][Full Text] [Related]
19. Sustained decreases in platelet count associated with multiple, regular plateletpheresis donations.
Lazarus EF; Browning J; Norman J; Oblitas J; Leitman SF
Transfusion; 2001 Jun; 41(6):756-61. PubMed ID: 11399815
[TBL] [Abstract][Full Text] [Related]
20. Apheresis platelets are more frequently associated with adverse reactions than pooled platelets both in recipients and in donors: a study from French hemovigilance data.
Daurat A; Roger C; Gris J; Daurat G; Feissel M; Le Manach Y; Lefrant J; Muller L
Transfusion; 2016 Jun; 56(6):1295-303. PubMed ID: 26814984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
